We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$16.7B
AUM Growth
+$2.72B
Cap. Flow
+$2.51B
Cap. Flow %
15.03%
Top 10 Hldgs %
35.19%
Holding
1,938
New
561
Increased
410
Reduced
355
Closed
390

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$309M
2
NXPI icon
NXP Semiconductors
NXPI
+$122M
3
NVDA icon
NVIDIA
NVDA
+$97.7M
4
AMGN icon
Amgen
AMGN
+$79M
5
SHEL icon
Shell
SHEL
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 8.51%
2 Technology 8.13%
3 Consumer Discretionary 5.54%
4 Financials 4.12%
5 Communication Services 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALM icon
626
Cal-Maine
CALM
$4.13B
$2.05M 0.01%
19,884
+11,884
+149% +$1.12M
AON icon
627
Aon
AON
$78.3B
$2.03M 0.01%
5,664
-18,595
-77% -$6.84M
JKHY icon
628
Jack Henry & Associates
JKHY
$11B
$2.03M 0.01%
+11,589
New +$2.07M
CLDX icon
629
PUT
Celldex Therapeutics
CLDX
$3.02B
$2.01M 0.01%
79,700
INTC icon
630
PUT
Intel
INTC
$460B
$2M 0.01%
+100,000
New +$2.25M
PRU icon
631
Prudential Financial
PRU
$42.6B
$1.99M 0.01%
16,814
-4,769
-22% -$589K
ZBH icon
632
Zimmer Biomet
ZBH
$18.4B
$1.97M 0.01%
18,680
+4,133
+28% +$443K
R icon
633
Ryder
R
$9.9B
$1.96M 0.01%
12,522
-18,860
-60% -$2.95M
FMC icon
634
FMC
FMC
$1.48B
$1.96M 0.01%
+40,357
New +$2.36M
BIIB icon
635
CALL
Biogen
BIIB
$30.7B
$1.96M 0.01%
+12,800
New +$2.16M
NVRO
636
PUT
DELISTED
NEVRO CORP.
NVRO
$1.96M 0.01%
525,600
LUNG icon
637
Pulmonx
LUNG
$68M
$1.94M 0.01%
285,110
-1,206
-0.4% -$7.94K
KBWB icon
638
Invesco KBW Bank ETF
KBWB
$6.83B
$1.92M 0.01%
29,380
+22,480
+326% +$1.47M
MU icon
639
Micron Technology
MU
$988B
$1.91M 0.01%
22,713
+3,820
+20% +$389K
VERX icon
640
Vertex
VERX
$2.04B
$1.91M 0.01%
+35,777
New +$1.73M
TT icon
641
Trane Technologies
TT
$97.3B
$1.91M 0.01%
+5,166
New +$2.05M
MRSH
642
Marsh
MRSH
$91.4B
$1.91M 0.01%
+8,975
New +$1.99M
TSCO icon
643
Tractor Supply
TSCO
$15.8B
$1.9M 0.01%
35,855
UNIT
644
Uniti Group
UNIT
$2.26B
$1.9M 0.01%
345,812
+250,812
+264% +$1.42M
PHR icon
645
CALL
Phreesia
PHR
$656M
$1.9M 0.01%
75,500
+8,000
+12% +$171K
JNJ icon
646
CALL
Johnson & Johnson
JNJ
$617B
$1.88M 0.01%
13,000
-18,500
-59% -$2.87M
BRZE icon
647
Braze
BRZE
$2.82B
$1.87M 0.01%
+44,600
New +$1.62M
NEM icon
648
CALL
Newmont
NEM
$101B
$1.86M 0.01%
50,000
IREN icon
649
PUT
Iris Energy
IREN
$13.7B
$1.86M 0.01%
+189,500
New +$2.02M
PCRX icon
650
Pacira BioSciences
PCRX
$1.06B
$1.86M 0.01%
98,770
+70,220
+246% +$1.23M

Similar funds

Jefferies Financial Group's Q4 2024 Portfolio in Review

As of Q4 2024, Jefferies Financial Group held 1,938 positions worth $16.7B, up 19% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Jefferies Financial Group deployed $2.51B of net new capital in Q4 2024, opening 561 new positions and adding to 410 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,500,000 shares worth $49.3M.

By sector, the portfolio is most concentrated in Healthcare at 8.5% of assets, down from 9.8% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $309M trimmed.

  • Jefferies Financial Group's largest Q4 2024 buy was Agios Pharmaceuticals: 1,500,000 shares worth $49.3M.
  • Jefferies Financial Group added most to Amazon in Q4 2024, an estimated $349M increase.
  • Jefferies Financial Group's biggest Q4 2024 reduction was Apple, cutting an estimated $309M.
  • Jefferies Financial Group fully exited Kellanova in Q4 2024, selling an estimated $23.2M.
  • Jefferies Financial Group's ten largest holdings make up 35% of its $16.7B portfolio in Q4 2024.
  • Jefferies Financial Group opened 561 new positions and closed 390 in Q4 2024.
  • Jefferies Financial Group's portfolio value rose 19% quarter-over-quarter to $16.7B.

Based on Jefferies Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.